Figure 3From: miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis The CCK8 assay was performed after ATAD2 siRNA treatment. (a) A reduction of absorbance was observed (P < 0.05). (b) Clonogenic assays were performed with ATAD2-depleted cancer cells. The number of colonies formed by cells treated with ATAD2 siRNA was far fewer than that of control siRNA-treated cells (P < 0.05).Back to article page